🇺🇸 FDA
Patent

US 8658674

Thiophene analogues for the treatment or prevention of flavivirus infections

granted A61KA61K38/005A61K38/21

Quick answer

US patent 8658674 (Thiophene analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/005, A61K38/21, A61P, A61P1/16